Retatrutide is a synthetic tri-agonist peptide that activates GLP-1, GIP, and glucagon receptors. It has been studied for its potential effects on glucose regulation, energy balance, and body weight in preclinical and clinical research.
Note: Our products are for in vitro research purposes only and are not for human consumption. The statements made within the website have not been evaluated by the USA Food and Drug Administration.
Choosing a selection results in a full page refresh.
